InspireMD
- Country
- Ownership
- -
- Employees
- 66
- Market Cap
- -
- Introduction
InspireMD, Inc. is medical device company, which engages in the development and commercialization of its proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. Its products are marketed for use mainly in patients with acute coronary syndromes, notably acute myocardial infarction and saphenous vein graft coronary interventions. The company was founded in 2005 and is headquartered in Tel Aviv, Israel.
A Single-arm, Pivotal Study to Evaluate Acute Device and Technical Success of the CGuard Prime Carotid Stent System When Used in Conjunction to the ENROUTE Transcarotid Neuroprotection System in Patients Undergoing Carotid Artery Stenting Via the Transcarotid Artery Revascularization Approach
- Conditions
- Carotid Artery Diseases
- First Posted Date
- 2024-10-22
- Last Posted Date
- 2025-02-14
- Lead Sponsor
- InspireMD
- Target Recruit Count
- 50
- Registration Number
- NCT06653387
- Locations
- 🇺🇸
Washington University School of Medicine, Saint Louis, Michigan, United States
Safety and Efficacy of the CGuardâ„¢ Carotid Stent System in Carotid Artery Stenting
- Conditions
- Carotid Artery Stenosis
- Interventions
- Device: CGuard Carotid Stent implantation
- First Posted Date
- 2021-05-25
- Last Posted Date
- 2025-04-04
- Lead Sponsor
- InspireMD
- Target Recruit Count
- 317
- Registration Number
- NCT04900844
- Locations
- 🇺🇸
Columbia University Irving Medical Center, New York, New York, United States
🇺🇸Ascension, St. John Hospital, Detroit, Michigan, United States
🇺🇸Mercy Hospital, Saint Louis, Missouri, United States
MGuardâ„¢ Prime Embolic Protection Stent in Patients With Acute ST Elevation Myocardial Infarction
- Conditions
- ST Elevation Myocardial Infarction
- First Posted Date
- 2014-11-17
- Last Posted Date
- 2015-09-02
- Lead Sponsor
- InspireMD
- Target Recruit Count
- 63
- Registration Number
- NCT02292823
- Locations
- 🇳🇱
Onze Lieve Vrouwe Gasthuis, Amsterdam, Netherlands
OCT Study of the MGuard Prime Stent in Patients With Heart Attacks
- Conditions
- ST Segment Elevated Myocardial Infarction
- Interventions
- Device: MGuard PrimeDevice: Control BMS DES
- First Posted Date
- 2014-08-21
- Last Posted Date
- 2015-03-31
- Lead Sponsor
- InspireMD
- Registration Number
- NCT02222116
- Locations
- 🇬🇧
Norfolk and Norwhich Hospital, Norfolk, United Kingdom
MGuardâ„¢ Prime Stent System Clinical Trial in Patients With Acute ST Elevation Myocardial Infarction
- Conditions
- ST Elevation Myocardial Infarction
- Interventions
- Device: MGuard PrimeDevice: (BMS/DES)
- First Posted Date
- 2013-06-05
- Last Posted Date
- 2015-09-02
- Lead Sponsor
- InspireMD
- Target Recruit Count
- 310
- Registration Number
- NCT01869738
- Locations
- 🇺🇸
St. Vincent Medical Group, Indianapolis, Indiana, United States
🇺🇸Beaumont Hospital, Royal Oak, Michigan, United States
🇺🇸Alexian Brothers Medical Center, Elk Grove Village, Illinois, United States
Safety and Efficacy Study of MGuard Stent After a Heart Attack
- Conditions
- Myocardial Infarction
- Interventions
- Device: MGuardDevice: Control BMS or DES
- First Posted Date
- 2011-06-08
- Last Posted Date
- 2013-05-29
- Lead Sponsor
- InspireMD
- Target Recruit Count
- 433
- Registration Number
- NCT01368471
- Locations
- 🇵🇱
Szpital Uniwersytecki w Krakowie, Krakow, Poland
🇿🇦Milpark Hospital, Johannesburg, South Africa
🇵🇱Centrum Kardiologii Inwazyjnej GVM Carint, Oświęcim, Poland
The Israeli MGuard Registry
- Conditions
- Ischemic Heart DiseaseAcute Coronary SyndromeAcute Myocardial Infarction
- Interventions
- Device: MGuard Coronary Stent system
- First Posted Date
- 2009-06-17
- Last Posted Date
- 2014-03-06
- Lead Sponsor
- InspireMD
- Target Recruit Count
- 86
- Registration Number
- NCT00922337
- Locations
- 🇮🇱
Asaf Harofe Medical Center, Zrifin, Israel
🇮🇱Laniado Hospital, Natanya, Israel